Characterization of immortalized human podocytes infected with lentivirus as an in vitro model of viral infection-associated podocytopathy
American Journal of Clinical and Experimental Immunology · 2024 · 13 (5) · 204-214
DOI: 10.62347/bbcx1142 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2024. Verfasst von Peng Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Kidney Diseases, Jinling Hospital, Medical School of Nanjing University Nanjing 210002, Jiangsu, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Clinical Research Center for Kidney Diseases, Jinling Hospital, Medical School of Nanjing University Nanjing 210002, Jiangsu, China.
Zitieren
APA
Yu, P., Jin, X., Huang, W., Wang, J., Zhang, S., Ren, L., Zhang, H., & Shi, S. (2024). Characterization of immortalized human podocytes infected with lentivirus as an in vitro model of viral infection-associated podocytopathy. American Journal of Clinical and Experimental Immunology, 13(5), 204-214. https://doi.org/10.62347/bbcx1142
Vancouver
Yu P, Jin X, Huang W, Wang J, Zhang S, Ren L, et al. Characterization of immortalized human podocytes infected with lentivirus as an in vitro model of viral infection-associated podocytopathy. American Journal of Clinical and Experimental Immunology. 2024;13(5):204-214. doi:10.62347/bbcx1142
BibTeX
@article{Yu2024,
author = {Yu, Peng and Jin, Xi and Huang, Weijun and Wang, Jingjing and Zhang, Sipang and Ren, Lu and Zhang, Haitao and Shi, Shaolin},
title = {Characterization of immortalized human podocytes infected with lentivirus as an in vitro model of viral infection-associated podocytopathy},
journal = {American Journal of Clinical and Experimental Immunology},
year = {2024},
volume = {13},
number = {5},
pages = {204--214},
doi = {10.62347/bbcx1142}
}
EUVIMED